Objective To improve the therapeutic effect of acute non-lymphatic leukemia (ANLL).
目的：为提高急性非淋巴细胞性白血病(急非淋)的疗效。
Objective: to investigated the therapy effect and prognosis related factors in the Acute Non-lymphocytic leukemia (ANLL) patients.
目的：探讨我院急性非淋巴细胞性白血病(ANLL)患者的治疗效果及其预后相关因素。
Methods Expression of MPO was detected in bone marrow mononuclear cell (BMMNC) from 36 cases with ANLL and 30 normal controls by capillary electrophoresis (ce).
方法采用毛细管电泳(CE)电化学检测法检测36例ANLL患者及30例正常骨髓单个核细胞(BMMNC)中MPO表达。
The plasma concentration of thrombomodulin (TM) were measured in 29 cases of acute non-lymphocytic leukemia (ANLL). Plasma TM level significantly increased in ANLL patients.
本文对29例急性非淋巴细胞白血病(ANLL)患者的血浆血栓调节蛋白(TM)水平进行检测，发现ANLL组血浆TM水平比正常组明显升高。
AIM:To observe the pharmacokinetics and adverse drug reaction (ADR) after high dose cytarabine maintenanced chemotherapy in 5 children with acute nonlymphocytic leukemia (ANLL).
目的：了解大剂量阿糖胞苷化疗后，患者的药物动力学参数及不良反应。
AIM:To observe the pharmacokinetics and adverse drug reaction (ADR) after high dose cytarabine maintenanced chemotherapy in 5 children with acute nonlymphocytic leukemia (ANLL).
目的：了解大剂量阿糖胞苷化疗后，患者的药物动力学参数及不良反应。
应用推荐